Deerfield Management Company, L.P. (Series C) Twist Bioscience Corp Transaction History
Deerfield Management Company, L.P. (Series C)
- $4.35 Billion
- Q2 2025
A detailed history of Deerfield Management Company, L.P. (Series C) transactions in Twist Bioscience Corp stock. As of the latest transaction made, Deerfield Management Company, L.P. (Series C) holds 23,827 shares of TWST stock, worth $780,095. This represents 0.02% of its overall portfolio holdings.
Number of Shares
23,827
Previous 23,827
-0.0%
Holding current value
$780,095
Previous $935,000
6.31%
% of portfolio
0.02%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding TWST
# of Institutions
269Shares Held
72.5MCall Options Held
60.8KPut Options Held
58K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl6.4MShares$210 Million1.95% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI5.85MShares$192 Million0.4% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.83MShares$191 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.42MShares$178 Million0.01% of portfolio
-
William Blair Investment Management, LLC Chicago, IL3.91MShares$128 Million0.41% of portfolio
About Twist Bioscience Corp
- Ticker TWST
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 56,363,500
- Market Cap $1.85B
- Description
- Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...